Format

Send to

Choose Destination
Front Microbiol. 2016 Dec 26;7:2097. doi: 10.3389/fmicb.2016.02097. eCollection 2016.

Mycobacterium kansasii Subtype I Is Associated With Clarithromycin Resistance in China.

Author information

1
Graduate School, Peking Union Medical CollegeBeijing, China; Department of Respiratory and Critical Care Medicine, Beijing HospitalBeijing, China.
2
National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
3
Department of Geriatrics, Beijing Hospital Beijing, China.
4
Graduate School, Peking Union Medical CollegeBeijing, China; Department of Respiratory Medicine, Chinese-Japanese Friendship HospitalBeijing, China.

Abstract

Mycobacterium kansasii is the second most common cause of slowly growing non-tuberculous mycobacteria diseases in China. The aim of the present study was to analyze M. kansasii subtypes isolated from patients in China, and to explore the antimicrobial susceptibility of the differentiation among these diverse subtypes. A total of 78 M. kansasii strains from 16 provinces of China were enrolled in this study. Amikacin (AMK) was the most highly active against M. kansasii strains, and only 4 isolates (5.1%) exhibited in vitro resistance to AMK. The percentage of levofloxacin (LFX) resistant strains among the 78 M. kansasii isolates was 39.7% (31/78), which was significantly higher than that of moxifloxacin (16.7%, P = 0.001) and gatifloxacin (19.2%, P = 0.005). By using PCR-restriction fragment analysis of the hsp65 gene (PRA), all the isolates were classified as four different subtypes. Of these four subtypes, M. kansasii subtype I was the most frequent genotype in China, accounting for 71.8% (56/78) of M. kansasii isolates. Resistance to clarithromycin (CLA) was noted in 26.8% (15/56) of subtype I isolates, which was significant higher than that of other subtypes (4.5%, P = 0.031). DNA sequencing revealed that the presence of mutations in 23S rRNA was associated with 56.2% (9/16) of CLA-resistant M. kansasii isolates. In conclusion, our data demonstrate that AMK is the most active agent against M. kansasii in vitro, while the high proportion of CLA resistance is noted in M. kansasii isolates. In addition, the predominant subtype I is associated with CLA resistance in China.

KEYWORDS:

China; Mycobacterium kansasii; clarithromycin; drug susceptibility; subtype

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center